By: Denise Simon | Founders Code
SARS–CoV-2 is a specific virus that can cause COVID-19, a disease. Doctors and scientists from around the world are diligently at task when it comes to prevention outside the scope of vaccines which is favorable to restoring the normal human conditions of everyday life. The Minister of Defense Surgeon General in Great Britain has issued an intriguing report regarding a repellent. This is experimental work and has not been externally peer-reviewed.
Defence Minister Jeremy Quin said: “We are sharing our preliminary findings today so others can take forward additional research to confirm and expand on our findings.
Dstl has been supporting the COVID19 response since February through lab-based research and testing, and deployment of scientific staff across Government. From working in partnership with Public Health England (PHE) and the National Health Service (NHS) to studying how the virus behaves, Dstl scientists are playing a vital role in the Government’s coronavirus response. Since the start of the pandemic, Dstl scientists have sped up testing patients for the virus, produced vital fluid used to test PPE ensuring NHS staff were kept safe and published research on how the virus survives in different environments.
As part of the scientific contribution to understanding the virus, Dstl has also built a Polymerase chain reaction (PCR) diagnostics capability and provided key expertise in assessment, statistics, and analysis capability. The PCR is a method widely used to rapidly make millions to billions of copies of a specific DNA sample, allowing scientists to take a very small sample of DNA and amplify it to a large enough amount to study in detail.
Two experimental approaches were adopted: assessment of the anti-viral activity of the product when applied directly to the virus as a liquid drop, and assessment of the product following its application to latex ‘synthetic skin’.
One minute liquid suspension tests indicated that Mosi-guard Natural® has anti-viral activity against SARS-CoV-2 England-2 isolate if mixed with the virus in the liquid phase. Additionally, viral studies on latex indicated that Mosi-guard Natural had antiviral activity against SARS-CoV-2 England-2 isolate.
This research paper demonstrates preliminary findings on the effectiveness of Citriodiol against COVID-19. The publication of this work is intended to act as the foundation for other scientific bodies who are researching the virus and possible solutions. Dstl is hopeful that the findings in this research can be used as a springboard for other organizations to expand and develop the research, as well as to confirm the findings in this publication.